The p16/p15 proteins encoded by CDKN2A/CDKN2B are known to be associated with telomerase activation and cancer progression [24,25] as well as to induce cell cycle arrest by inhibition of CDK4 kinase [26]. The gene discussed is CDKN2B; the disease is cancer.